AGC Advises Curoverse on Its Sale to Veritas Genetics

AGC Partners is pleased to announce that its client, Curoverse, the preeminent computing and bioinformatics company behind the Personal Genome Project (PGP) at Harvard Medical School, and creator of the open-source platform Arvados, has been acquired by Veritas Genetics. The acquisition will expand Veritas' existing relationship with Curoverse and enable the company to increase the production capacity and data management infrastructure of Arvados as well as effectively deploy AI and machine learning on the platform, which is slated to exceed 10 petabytes of genomic data this year. The Curoverse acquisition was made for an undisclosed amount, and the company will operate as a wholly owned subsidiary of Veritas Genetics. With a team led by Hugh Hoffman and Fred Joseph, AGC Partners acted as sole financial advisor to Curoverse.